Kerala Ayurveda Ltd. (KERALAYUR) Share Price Rises 9.99% Today

Kerala Ayurveda Ltd. Share Price Today rose to Rs 207, up 9.99%, taking the micro cap company’s market capitalisation to Rs 222.35 crore.

Kerala Ayurveda Ltd. Share Price moved up to Rs 207 on 19 August 2026, a gain of 9.99% over the previous close of Rs 188.2, lifting the company’s market capitalisation to Rs 222.35 crore. In today’s Kerala Ayurveda Ltd. Stock News, the verified data confirms a notable same-day price rise in a micro cap counter, with the stock also featuring in the TOP_GAINERS screen.

The move matters because the stock did not just edge higher; it added Rs 18.8 in a single session and traded at an intraday high equal to the current price of Rs 207. For investors tracking Kerala Ayurveda Ltd. Share Price Today, that places the counter firmly among the market movers in Healthcare during this session. At the same time, the supplied data does not establish a company-specific catalyst behind the move, so the rise should be understood first through price action, valuation and sector context rather than through an assumed trigger.

From a financial lens, Kerala Ayurveda Ltd. Share Price carries a market value of Rs 222.35 crore, a P/E ratio of -10.14, a P/B ratio of -12.12, ROE of -183.03, ROCE of -0.45, EPS of -20.41 and dividend yield of 0. These numbers make the stock relevant not only because it is rising today, but also because the underlying profitability and valuation profile differs sharply from large parts of its Pharmaceuticals & Drugs peer set. In this Univest analysis, the focus is on what happened, what the numbers show and what investors should monitor next.

Kerala Ayurveda Ltd. (KERALAYUR) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 207
Previous Close	Rs 188.2
Today's Change	+Rs 18.8 (+9.99%)
Day Open	Rs 204
Day High	Rs 207
Day Low	Rs 196.4
Current Volume (BSE)	88,974
BSE Traded Volume	88,974
Combined NSE + BSE Volume	88,974
Turnover	Rs 1.84 crore
Market Capitalisation	Rs 222.35 crore
Market Cap Category	Micro Cap

Kerala Ayurveda Ltd. (KERALAYUR) traded at Rs 207. versus the previous close of Rs 188.2, a rise of 9.99%. The stock opened at Rs 204, reached Rs 207, touched Rs 196.4. Reported volume was 88,974.

Kerala Ayurveda Ltd. (KERALAYUR) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 222.35 crore
P/E Ratio	-10.14x
P/B Ratio	-12.12x
ROE	-183.03%
ROCE	-0.45%
EPS	Rs -20.41
Dividend Yield	0%

Kerala Ayurveda Ltd. was valued at a P/E ratio of -10.14x, a P/B ratio of -12.12x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -183.03% and ROCE of -0.45%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs -20.41, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Kerala Ayurveda Ltd. Fundamental Analysis begins with scale and valuation. The company’s market capitalisation stands at Rs 222.35 crore, which places it in the micro cap segment even though it operates in the broad Healthcare sector and the Pharmaceuticals & Drugs industry. Kerala Ayurveda Ltd. Share Price is therefore reacting in a smaller-cap setting where single-day price moves can attract fast investor attention. But market cap indicates company size, not business quality by itself, so the next layer is profitability and valuation.

The supplied P/E ratio is -10.14. A negative P/E generally reflects negative trailing earnings rather than a conventional earnings multiple that can be compared on a like-for-like basis with profitable companies. The EPS is -20.41, which means earnings attributable to each share are currently negative on the supplied basis. Kerala Ayurveda Ltd. Share Price Today is thus rising even though the earnings snapshot remains weak.

The P/B ratio is -12.12, while ROE is -183.03 and ROCE is -0.45. ROE measures return generated on shareholder equity, and such a deeply negative reading points to a very weak recent return profile. ROCE, which measures returns on capital employed, is also below zero at -0.45, showing that returns on operating capital are not yet healthy on the supplied numbers. In Kerala Ayurveda Ltd. Stock Analysis, these figures are important because they challenge any simplistic reading of today’s price gain as a sign of already strong underlying profitability.

EPS of -20.41 adds context to the negative P/E, while the dividend yield of 0 indicates that the stock is not offering a historical current cash payout relative to the prevailing price in this dataset. Kerala Ayurveda Ltd. Share Price and Kerala Ayurveda Ltd. Financial Results related search intent therefore meet a mixed picture: strong price action today, but profitability ratios that remain weak relative to profitable peers.

For Univest readers, the balanced takeaway is straightforward. Kerala Ayurveda Ltd. Share Price is drawing attention because of today’s move, but the supplied fundamentals do not show a high-return profile at present. That does not explain the rise, nor does it invalidate it; it simply means price momentum and financial quality are not telling the same story right now. That makes sector and peer comparison especially important.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	-10.14x
Benchmark Median P/E	25.85x
Benchmark Average P/E	36.08x
Benchmark P/E Range	2.7x to 302.04x
Company P/B Ratio	-12.12x
Benchmark Median P/B	1.87x
Company ROE	-183.03%
Benchmark Median ROE	10.49%
Company ROCE	-0.45%
Benchmark Median ROCE	12.97%
Company Market Capitalisation	Rs 222.35 crore
Benchmark Median Market Cap	Rs 138.84 crore

Kerala Ayurveda Ltd. (KERALAYUR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Kerala Ayurveda Ltd. (KERALAYUR) has a P/E ratio of -10.14x, which is below the benchmark median of 25.85x, a difference of -139.23%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Kerala Ayurveda Ltd. (KERALAYUR) has a ROE of -183.03%, which is below the benchmark median of 10.49%, a difference of -1,844.8%. Kerala Ayurveda Ltd. (KERALAYUR) has a ROCE of -0.45%, which is below the benchmark median of 12.97%, a difference of -103.47%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Kerala Ayurveda Ltd. Share Price is moving within the Healthcare sector and the Pharmaceuticals & Drugs industry, and the supplied benchmark covers 136 companies in the same industry. That benchmark is useful because it shows where the company stands on valuation, profitability and size against a broad directly comparable universe rather than against the entire Indian Stock Market.

On P/E, Kerala Ayurveda Ltd. carries a company P/E of -10.14, while the same-industry benchmark median is 25.85 and the average is 36.08 across 105 companies with P/E data. The range runs from 2.7 to 302.04. Since Kerala Ayurveda Ltd. Share Price reflects negative earnings, its P/E sits outside the normal profitable band suggested by the positive median and average. This is not a case of the stock merely trading at a lower conventional earnings multiple than sector peers; it is a case of a negative earnings base.

On price-to-book, the company’s P/B is -12.12. The benchmark median is 1.87, the average is 2.47, and the reported range stretches from -12.12 to 16.81 across 134 companies. Kerala Ayurveda Ltd. is therefore at the minimum end of the supplied P/B range. That makes Kerala Ayurveda Ltd. Share Price unusual within its peer group on this metric.

Profitability comparisons tell a similarly weak story relative to industry norms. Company ROE is -183.03 against a benchmark median of 10.49 and average of 8.1 across 135 companies. Company ROCE is -0.45 versus a median of 12.97 and an average of 15.53 across 135 companies. In size terms, the company’s market capitalisation of Rs 222.35 crore is above the benchmark median of Rs 138.84 crore but below the benchmark average of Rs 488.13 crore, with the full range running from Rs 5.94 crore to Rs 2,752.33 crore.

For Univest and for anyone scanning Stocks in News, the industry context is clear. Kerala Ayurveda Ltd. Share Price Today is outperforming on the screen, but its supplied valuation and profitability metrics remain weaker than broad same-industry medians and averages. That gap between market action and sector-relative financial profile is exactly why the stock is being closely watched.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,752.33	0	0.69	-2.89	-0.26
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,724.51	51.17	2.03	-0.78	8.31
Beta Drugs Ltd.	BETA	2,697.08	62.93	9.96	18.65	22.17
Hikal Ltd.	HIKAL	2,622.61	0	2.25	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,531.8	0	8.68	0	5.36

Kerala Ayurveda Ltd. (KERALAYUR) has a P/E ratio of -10.14x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -183.03% compares with a peer median of 0% across the companies shown in the table. ROCE stood at -0.45% versus the displayed peer median of 8.31%, providing a capital-efficiency comparison. Kerala Ayurveda Ltd. (KERALAYUR) has a market capitalisation of Rs 222.35 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Kerala Ayurveda Ltd. Share Price can also be judged against specific listed peers in Pharmaceuticals & Drugs. The peer set supplied includes Dishman Carbogen Amcis Ltd., Ind-Swift Laboratories Ltd., Beta Drugs Ltd., Hikal Ltd., Panacea Biotec Ltd., Solara Active Pharma Sciences Ltd., Sai Parenteral's Ltd., Fredun Pharmaceuticals Ltd., Venus Remedies Ltd. and Hester Biosciences Ltd. These are all materially larger by market capitalisation, with values ranging from Rs 2,057.26 crore for Hester Biosciences to Rs 2,752.33 crore for Dishman Carbogen Amcis, versus Kerala Ayurveda’s Rs 222.35 crore.

That size gap matters because Kerala Ayurveda Ltd. Share Price is being assessed against companies with much broader market value footprints. On profitability, the company’s ROE of -183.03 is far below the peer figures visible in the snapshot, including -2.89 for Dishman Carbogen Amcis, -0.78 for Ind-Swift Laboratories, 18.65 for Beta Drugs, 15.22 for Hikal, 0 for Panacea Biotec, 17.23 for Solara, 13.9 for Sai Parenteral's, 11.42 for Fredun Pharmaceuticals, 9.85 for Venus Remedies and 16.17 for Hester Biosciences.

ROCE comparison also leaves Kerala Ayurveda behind most peers. Its ROCE is -0.45, compared with -0.26 for Dishman Carbogen Amcis, 8.31 for Ind-Swift Laboratories, 22.17 for Beta Drugs, 16.15 for Hikal, 5.36 for Panacea Biotec, 15.34 for Solara, 12.97 for Sai Parenteral's, 13.15 for Fredun Pharmaceuticals, 7.89 for Venus Remedies and 14.12 for Hester Biosciences. On P/E, Kerala Ayurveda’s -10.14 contrasts with 51.17 for Ind-Swift, 62.93 for Beta Drugs, 167.79 for Sai Parenteral's, 54.45 for Fredun and 20.81 for Venus Remedies, while Hester stands at 15.22.

On P/B, Kerala Ayurveda’s -12.12 is well below peers such as 0.69 for Dishman Carbogen Amcis, 2.03 for Ind-Swift, 9.96 for Beta Drugs, 2.25 for Hikal, 8.68 for Panacea Biotec, 2.07 for Solara, 3.07 for Sai Parenteral's, 8.13 for Fredun, 3.52 for Venus Remedies and 4.56 for Hester. For Univest readers following Kerala Ayurveda Ltd. Share Price News, the peer picture reinforces the same theme: today’s top gainer move stands out more than the company’s current relative profitability profile.

Why Investors Are Watching Kerala Ayurveda Ltd.

Kerala Ayurveda Ltd. Share Price is being watched because today’s move combines a clear top-gainer style price rise with a financial profile that looks very different from broad sector medians. In other words, the stock is attracting attention not only for where it traded today, but also for the contrast between strong price action and weak reported profitability metrics.

• Verified price action: the stock rose 9.99% to Rs 207 from Rs 188.2, with a day high of Rs 207 and turnover of Rs 1.84 crore.
• Market positioning: it is a micro cap company with a market capitalisation of Rs 222.35 crore and appeared in the TOP_GAINERS event screen.
• Fundamental context: P/E is -10.14, P/B is -12.12, ROE is -183.03, ROCE is -0.45, EPS is -20.41 and dividend yield is 0.
• Sector positioning: same-industry median P/E is 25.85, median P/B is 1.87, median ROE is 10.49 and median ROCE is 12.97.
• Peer context: most listed peers in the supplied set are far larger and generally show stronger ROE and ROCE readings.

What should investors monitor next? Kerala Ayurveda Ltd. Share Price Update watchers will likely focus on whether the stock can sustain trade near its intraday high, whether turnover remains elevated after today’s move, and whether future financial data changes the current gap between market action and profitability metrics. Univest would also watch how the stock behaves relative to the broader Pharmaceuticals & Drugs peer set rather than isolating a single day’s move.

About Kerala Ayurveda Ltd.

Kerala Ayurveda Ltd. operates in the Healthcare sector and is classified under the Pharmaceuticals & Drugs industry in the supplied dataset. That places the company in a segment of the market where investors often compare businesses through valuation ratios, profitability indicators and peer positioning within the listed pharma and healthcare universe.

Although the supplied data does not provide a long business description, revenue mix or segment breakdown, the available classification still gives useful context for Kerala Ayurveda Ltd. Share Price and Kerala Ayurveda Ltd. Company News searches. The company is part of an industry benchmark covering 136 same-industry companies, which means it sits inside a well-populated peer group with a wide spread of market capitalisations, valuation multiples and profitability outcomes. In size terms, Kerala Ayurveda’s market capitalisation of Rs 222.35 crore is above the benchmark median of Rs 138.84 crore but far below the average of Rs 488.13 crore, underlining its smaller listed footprint within the industry.

That positioning matters for stock analysis because smaller pharma and healthcare counters can see stronger day-to-day price action than larger names, especially when they enter screens such as top gainers. Kerala Ayurveda Ltd. Share Price Today therefore deserves attention as a market event, but the company’s current reported ratios also show that its financial profile is not yet aligned with the stronger profitability readings seen across many sector peers. For Univest readers, the company context is best understood as a small listed Pharmaceuticals & Drugs player currently in focus because of a notable single-day price rise.

Track Kerala Ayurveda Ltd. Share Price on Univest

Use Kerala Ayurveda Ltd. (KERALAYUR) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors following Kerala Ayurveda Ltd. Share Price can use Univest to track live price moves, BSE activity, market capitalisation, valuation ratios, profitability indicators and broader market insights in one place. Kerala Ayurveda Ltd. Share Price Today, 52-week levels, shareholding pattern updates when available, peer comparison and sector benchmark data all help place a single day’s move in context.

For readers looking beyond Kerala Ayurveda Ltd. Stock News and Kerala Ayurveda Ltd. Latest News, Univest is useful for comparing stock performance with industry medians, checking whether a move is backed by turnover and reviewing how ratios such as P/E, P/B, ROE, ROCE, EPS and dividend yield stack up across peers. That kind of context matters when a stock becomes one of the market movers in today’s session.

Frequently Asked Questions

Why is Kerala Ayurveda Ltd. Share Price rising today?

Ans. Kerala Ayurveda Ltd. Share Price rose 9.99% today to Rs 207 from the previous close of Rs 188.2. The supplied data confirms the price rise and top-gainer status, but it does not establish a company-specific catalyst behind the move.

What is Kerala Ayurveda Ltd. Share Price Today?

Ans. Kerala Ayurveda Ltd. Share Price Today is Rs 207 in the supplied market snapshot. The stock opened at Rs 204, touched a day high of Rs 207 and a day low of Rs 196.4 during the session.

How much did Kerala Ayurveda Ltd. stock gain in today’s trade?

Ans. Kerala Ayurveda Ltd. stock gained Rs 18.8 in absolute terms and 9.99% in percentage terms versus its previous close of Rs 188.2. That made it one of the notable Stocks Rising Today in the supplied TOP_GAINERS screen.

What is the market capitalisation of Kerala Ayurveda Ltd.?

Ans. Kerala Ayurveda Ltd. has a market capitalisation of Rs 222.35 crore based on the supplied data. That places the stock in the Micro Cap category, which is relevant when judging the significance of today’s price rise.

Which exchange recorded Kerala Ayurveda Ltd. trading volume today?

Ans. The supplied data shows Kerala Ayurveda Ltd. trading volume of 88,974 shares on BSE, and total reported volume is also 88,974 shares. Turnover for the session stood at Rs 1.84 crore in the same snapshot.

Is Kerala Ayurveda Ltd. profitable based on the supplied metrics?

Ans. The supplied profitability snapshot looks weak. Kerala Ayurveda Ltd. reports EPS of -20.41, ROE of -183.03 and ROCE of -0.45, while its P/E ratio is -10.14, indicating negative earnings on the reported basis.

How does Kerala Ayurveda Ltd. compare with its industry on valuation?

Ans. Kerala Ayurveda Ltd. has a P/E of -10.14 against the same-industry median of 25.85 and average of 36.08. Its P/B is -12.12 versus an industry median of 1.87 and average of 2.47 in the supplied benchmark.

How does Kerala Ayurveda Ltd. compare with the industry on profitability?

Ans. Kerala Ayurveda Ltd. reports ROE of -183.03 and ROCE of -0.45. The same-industry benchmark shows median ROE of 10.49 and median ROCE of 12.97, so the company’s current profitability profile sits below those reference levels.

Who are the listed peers compared with Kerala Ayurveda Ltd.?

Ans. The supplied peer set includes Dishman Carbogen Amcis, Ind-Swift Laboratories, Beta Drugs, Hikal, Panacea Biotec, Solara Active Pharma Sciences, Sai Parenteral's, Fredun Pharmaceuticals, Venus Remedies and Hester Biosciences within Pharmaceuticals & Drugs.

What should investors monitor after today’s Kerala Ayurveda Ltd. Share Price rise?

Ans. Investors can monitor whether Kerala Ayurveda Ltd. Share Price holds near the session high of Rs 207, whether turnover stays active after today’s 9.99% gain, and whether future financial metrics improve relative to sector and peer benchmarks.